Global Arteriovenous Malformations (AVMs) Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Arteriovenous Malformations (AVMs) Market, By Type (True Arteriovenous Malformation, Occult or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Others), Stages (Stage I (Quiescence), Stage II (Expansion), Stage III (Destruction), Stage IV (Decompensation), Others), Treatment (Diagnosis, Medication, Surgery, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Arteriovenous Malformations (AVMs) Market Market Analysis and Insights: Global Arteriovenous Malformations (AVMs) Market

Global Arteriovenous malformations (AVMs) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 6.70% in the above-mentioned research forecast period. Emerging markets and continuous rising prevalence of neurological disorders are the factors responsible for the growth of this market.

However, increasing company initiatives to provide better treatment and rising investment by biotechnology and pharmaceutical industries in R&D drive the global arteriovenous malformations (AVMs) market. Moreover, technological advancement in treatment & diagnosis and favourable reimbursement policies also boost up the market growth. But, the high cost associated with treatment and limited availability of facilities in developing countries may hamper the global arteriovenous malformations (AVMs) market.

Arteriovenous malformations (AVMs) are an abnormal tangle of a blood vessel that connects arteries & veins and disrupt the normal blood flow and oxygen circulation. When AVMs occur in any part of the body the surrounding tissues may not get enough oxygen and the affected vein & arteries get weaken and ruptured. If AVMs are in the brain and ruptured, it may cause bleeding in the brain which leads to the connection of haemorrhage, stroke, or brain damage. AVMs can occur anywhere in the body but majorly they are found in the brain and spine.

Brain AVMs are very rare and occur in less than 1 percent of the general population. AVMs are more common in males than in females. Most people with AVMs will never have any problems. However, nearly 12 % of people with AVMs do have some symptoms. According to the studies, less than 4 % of AVMs haemorrhage occurs and death as a direct result of an AVM happens in about 1 % of people with AVMs.

This arteriovenous malformations (AVMs) market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Arteriovenous malformations (AVMs) Market Scope and Market Size

The arteriovenous malformations (AVMs) market is segmented on the basis of type, stages, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the arteriovenous malformations (AVMs) market is segmented into true arteriovenous malformation, occult or cryptic, cavernous malformations, venous malformation, hemangioma, dural fistula and others.
  • On the basis of stages, the arteriovenous malformations (AVMs) market is segmented into stage I (quiescence), stage II (expansion), stage III (destruction), stage IV (decompensation) and others.
  • On the basis of treatment, the arteriovenous malformations (AVMs) market is segmented into diagnosis, medication, surgery and others. Diagnosis segment further divided into cerebral angiography, computerized tomography (CT), magnetic resonance imaging (MRI), transcranial doppler ultrasound and others. Medication segment further divided into anti-seizures, pain relievers and others.
  • On the basis of end-users, the arteriovenous malformations (AVMs) market is segmented into hospitals, specialty clinics, home healthcare and others.
  • On the basis of distribution channel, the arteriovenous malformations (AVMs) market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Arteriovenous malformations (AVMs) Market Country Level Analysis

Arteriovenous malformations (AVMs) market is analysed and market size information is provided by country, type, stages, treatment, end-users and distribution channel as referenced above.

The countries covered in the Arteriovenous malformations (AVMs) market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the increased consumption of neurological drugs for the treatment of neurological disorders. Europe accounts the second largest market share due to increased neurological disorders and presence of refined medical facilities. Asia Pacific region is the fastest growing region in the upcoming years due to rising healthcare infrastructure and rising government and pharmaceutical initiatives for the better treatment.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Arteriovenous malformations (AVMs) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Arteriovenous malformations (AVMs) Market Share Analysis

Arteriovenous malformations (AVMs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to arteriovenous malformations (AVMs) market.

The major players covered in the arteriovenous malformations (AVMs) market are Electrical Geodesics Inc., Siemens Healthcare., Masimo Corporation., Esaote., Shimadzu Corporation., Toshiba Medical Systems Corporation., Carestream Health., Philips Healthcare, Pfizer Inc, Eli Lilly and Company, Novartis AG, F. Hoffmann-La Roche Ltd and Eisai Co., Ltd, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Arteriovenous malformations (AVMs) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions